Inhibition of angiogenesis by synthetic matrix metalloprotease i

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514323, 514563, 514620, 514626, A61K 31405, A61K 31445

Patent

active

056961472

ABSTRACT:
Synthetic mammalian matrix metalloprotease inhibitors are useful in controlling angiogenesis. These compounds are thus useful in controlling the growth of tumors and in controlling neovascular glaucomas.

REFERENCES:
patent: 4291048 (1981-09-01), Gold
patent: 4558034 (1985-12-01), Galardy et al.
patent: 4599361 (1986-07-01), Dickens et al.
patent: 4681894 (1987-07-01), Murray et al.
patent: 4698342 (1987-10-01), Crosby
patent: 4743587 (1988-05-01), Dickens et al.
patent: 4918105 (1990-04-01), Cartwright et al.
patent: 4943587 (1990-07-01), Cetenko et al.
patent: 4996358 (1991-02-01), Handa et al.
patent: 5183900 (1993-02-01), Galardy et al.
patent: 5189178 (1993-02-01), Galardy et al.
patent: 5239078 (1993-08-01), Galardy et al.
patent: 5304604 (1994-04-01), Davidson et al.
patent: 5453438 (1995-09-01), Campion et al.
Dialog.TM. Computer Database Abstract of International (PCT) Patent No. WO 91/11193 (Jan. 25, 1991).
Dialog.TM. Computer Database Abstract of European Patent Application No. 0424193 (Apr. 24, 1991).
Mullins et al., "The role of proteinases in cellular invasiveness" Biochem. Biophys. Acta (1983) 695:177-214.
Reich et al., "Effects of inhibitors of plasminogen activator, serine proteinases, and collagenases IV on the invasion of basement membranes by metastatic cells" (1988) Cancer Res. (1988) 48:3307-3312.
Nishino et al., "Design of potent reversible inhibitors for thermolysin. Peptides containing zinc coordinating ligands and their use in affinity chromatography" Biochemistry (1979) 18:4340-4347.
Nishino et al., "Peptide hydroxamic acids an inhibitors of thermolysin" Biochemistry (1978) 17:2846-2850.
G. S. Schultz et al., "Treatment of Alkali-Injured Corneas With a Synthetic Inhibitor of Matrix Metalloprotease" Investigative Ophthalmology & Visual Science, vol. 33, No. 12, pp. 3325-3331, Nov. 1992.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of angiogenesis by synthetic matrix metalloprotease i does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of angiogenesis by synthetic matrix metalloprotease i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of angiogenesis by synthetic matrix metalloprotease i will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1608106

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.